Abstract
This chapter explores the legal and ethical challenges surrounding gene editing, specifically the controversy surrounding the patenting of living organisms, transgenic animals, and human gene patents. The chapter also discusses the legal implications of gene patenting, focusing on the landmark case of Association for Molecular Pathology v. Myriad Genetics, Inc. Furthermore, the chapter explores the revolutionary gene editing technology known as CRISPR and the ongoing legal battles over patent ownership and licensing agreements. This chapter highlights the complexities and limitations of gene editing and the importance of engaging the public in the scientific discourse.
Animals, whom we have made our slaves, we do not like to consider our equal.
Charles Darwin
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Murray, F. (2011). Patenting life: How the Oncomouse patent changed the lives of mice and men. In Making and unmaking intellectual property: Creative production in legal and cultural perspective.
Stallman, R. (2002). Are US patents too broad? Science, 297(5580), 336–336.
Sherkow, J. S., & Greely, H. T. (2015). The history of patenting genetic material. Annual Review of Genetics, 49, 161–182.
Cavalli-Sforza, L. L. (2005). The human genome diversity project: Past, present and future. Nature Reviews Genetics, 6(4), 333–340.
Cunningham, H. (1998). Colonial encounters in postcolonial contexts: Patenting indigenous DNA and the Human Genome Diversity Project. Critique of Anthropology, 18(2), 205–233.
Tejera, V. (1998). Tripping over property rights: Is it possible to reconcile the convention on biological diversity with article 27 of the TRIPs agreement. New England Law Review, 33, 967.
Dhar, B. (2013). The convention on biological diversity and the TRIPS agreement: Compatibility or conflict?. In Trading in knowledge (pp. 77–88). Routledge.
Stasi, A., & Rodrigues, I. P. (2019). Dealing with patent fragmentation in genetics: Can patent pools facilitate the development of CRISPR gene-editing technology? Journal of law and Medicine, 26(4), 866–873.
Barrangou, R., & Doudna, J. A. (2016). Applications of CRISPR technologies in research and beyond. Nature biotechnology, 34(9), 933–941.
Ledford, H. (2015). CRISPR, the disruptor. Nature, 522(7544), 20–25.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Stasi, A. (2023). The Limits and Challenges of Gene Editing. In: Biotechnology Law and Policy. Springer, Singapore. https://doi.org/10.1007/978-981-99-2135-5_6
Download citation
DOI: https://doi.org/10.1007/978-981-99-2135-5_6
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-99-2134-8
Online ISBN: 978-981-99-2135-5
eBook Packages: Law and CriminologyLaw and Criminology (R0)